Effects of cyclosporin on cholesterol 27-hydroxylation and LDL receptor activity in HepG2 cells

Journal of Lipid Research

Volumn 37, Issue 1, 1996, Pages 179-191

  Winegar, Deborah A ^a   Salisbury, Jo A ^a   Sundseth, Scott S ^a   Hawke, Roy L ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

2 hydroxypropyl cyclodextrin; 27 hydroxycholesterol; ACAT

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CYCLOSPORIN; LOW DENSITY LIPOPROTEIN RECEPTOR; OXYGENASE; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CELLULAR DISTRIBUTION; CHOLESTEROL ESTERIFICATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; STEROID HYDROXYLATION;

BIOLOGICAL TRANSPORT; CYCLOSPORINE; CYTOCHROME P-450 CYP27A1; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; LIPOPROTEINS, LDL; LIVER; MITOCHONDRIA; RECEPTORS, LDL; SOLUBILITY; STEROID HYDROXYLASES; TUMOR CELLS, CULTURED;

EID: 0030053468     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Goldstein, J. L., and M. S. Brown. 1984. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate plasma cholesterol. J. Lipid Res. 25: 1450-1461.
2. Goldstein, J. L., and M. S. Brown. 1977. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 46: 897-930.
3. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
4. Pittman, R. C. T. E. Carew, A. D. Attie, J. L. Witztum, Y. Watanabe, and D. Steinberg. 1982. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and receptor-deficient mutant rabbits. J. Biol. Chem. 257: 7994-8000.
5. Rudling, M. 1992. Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo. J. Lipid Res. 33: 193-501.
6. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature. 343: 425-430.
7. Smith, L. L., and B. H. Johnson. 1989. Biological activities of oxysterols. Free Radical Biol. Med. 7: 285-332.
8. Taylor, F. R. 1992. Correlation among oxysterol potencies in the regulation of the degradation of 3-hydroxy-3-methylglutaryl CoA reductase, the repression of 3-hydroxy-3-methylglutaryl CoA synthase and affinities for the oxysterol receptor. Biochem. Biophys. Res. Commun. 186: 182-189.
9. Bellosta, S., A. Corsini, F. Bernini, A. Granata, G. Didoni, M. Mazzotti, and R. Fumagalli. 1993. 27-Hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells. FEBS Lett. 332: 115-118.
10. Esterman, A. L., H. Baum, N. B. Javitt, and G. J. Darlington. 1983. 26-Hydroxycholesterol: regulation of hydroxymethylglutaryl-CoA reductase activity in Chinese hamster ovary cell culture. J. Lipid Res. 24: 1304-1309.
11. Pinkerton, F. D., C. H. Spilman, D. P. Via, and G. J. Schroepfer, Jr. 1993. Differing effects of three oxysterols on low density lipoprotein metabolism in HepG2 cells. Biochem. Biophys. Res. Commun. 193: 1091-1097.
12. Lorenzo, J. L., M. Allorio, F. Bernini, A. Corsini, and R. Fumagalli. 1987. Regulation of low density lipoprotein metabolism by 26-hydroxycholesterol in human fibroblasts. FEBS Lett. 218: 77-80.
13. Miao, E., S. R. Wilson, and N. B. Javitt. 1988. Cholesterol metabolism: effect of 26-thiacholesterol and 26-amino-cholesterol, analogues of 26-hydroxycholesterol, on cholesterol synthesis and low-density-lipoprotein binding. Biochem. J. 255: 1049-1055.
14. Takagi, K., J. G. Alvarez, M. F. Favata, J. M. Trzaskos, and J. F. Strauss. 1989. Control of low density lipoprotein receptor gene promoter activity: ketoconazole inhibits serum lipoprotein but not oxysterol suppression of gene transcription. J. Biol. Chem. 264: 12352-12357.
15. Kempen, J. J., K. Van Soon, L. H. Cohen, M. Griffioen, H. Verboom, and L. Havekes. 1987. Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activity in HepG2 cells. Biochem. Pharmacol. 36: 1245-1249.
16. Gupta, A., R. C. Sexton, and H. Rudney. 1986. Modulation of regulatory oxysterol formation and low density lipoprotein suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. J. Biol. Chem. 261: 8348-8356.
17. Kandutsch, A. A., F. R. Taylor, and E. P. Shown. 1984. Different forms of the oxysterol-binding protein. Binding, kinetics and stability. J. Biol. Chem. 259: 12388-12397.
18. Taylor, F. R., S. E. Saucier, E. P. Shown, E. J. Parish, and A. A. Kandutsch. 1984. Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. J. Biol. Chem. 259: 12382-12387.
19. Javitt, N. 1990. 26-Hydroxycholesterol: synthesis, metabolism, and biologic activities. J. Lipid Res. 31: 1527-1533.
20. Rennert, H., R. T. Fischer, J. G. Alvarez, J. M. Trzaskos, and J. F. Strauss III. 1990. Generation of regulatory oxysterols: 26-hydroxylation of cholesterol by ovarian mitochondria. Endocrinology. 127: 738-746.
21. Lund, E., O. Breuer, and I. Björkhem. 1992. Evidence that 24- and 27-hydroxylation are not involved in the cholesterol-induced down-regulation of hydroxymethylglutaryl-CoA reductase in mouse liver. J. Biol. Chem. 267: 25092-25097.
22. Andersson, S., D. L. Davis, H. Dahlback, H. Jornvall, and D. W. Russell. 1989. Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem. 264: 8222-8229.
23. Cali, J. J., and D. W. Russell. 1991. Characterization of human sterol 27-hydroxylase: a mitochondrial cytochrome P-450 that catalyzes multiple oxidation reactions in bile acid biosynthesis. J. Biol. Chem. 266: 7774-7778.
24. Reiss, A. B., K. O. Martin, N. B. Javitt, D. W. Martin, E. A. Grossi, and A. C. Galloway. 1994. Sterol 27-hydroxylase: high levels of activity in vascular endothelium. J. Lipid Res. 35: 1026-1030.
25. Björkhem, I., O. Andersson, U. Diczfalusy, B. Sevastik, R-J. Xiu, C. Duan, and E. Lund. 1994. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA. 91: 8592-8596.
26. Javitt, N. B. 1994. Bile acid synthesis from cholesterol: regulatory and auxiliary pathways. FASEB J. 8: 1308-1311.
27. Björkhem, I. 1992. Mechanism of degradation of the steroid side chain in the formation of bile acids. J. Lipid Res. 33: 455-472.
28. Cali, J. J., C-L. Hsieh, U. Francke, and D. W. Russell. 1991. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 266: 7779-7783.
29. Javitt, N. B., E. Kok, B. Cohen, and S. Burstein. 1982. Cerebrotendinous xanthomatosis: reduced serum 26-hydroxycholesterol. J. Lipid Res. 23: 627-630.
30. Kuriyama, M., J. Fujiyama, H. Yoshidome, S. Takenaga, K. Matsumuro, T. Kasama, K. Fukuda, T. Kuramoto, T. Hoshita, Y. Seyama, Y. Okatu, and M. Osame. 1991. Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of eight patients and review of the literature. J. Neurol. Sci. 102: 225-232.
31. Setoguchi, T., G. Salen, G. S. Tint, and E. H. Mosbach. 1974. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain. J. Clin. Invest. 531: 1391-1401.
32. Javitt, N. B. 1990. HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 4: 161-168.
33. Princen, H. M. G., R. Meijer, B. G. Wolthers, R. J. Vonk, and F. Kuipers. 1991. Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis. Biochem. J. 275: 501-505.
34. 3 by cyclosporin A. Biochem. J. 293: 203-206.
35. Levy, J., K. Budai, and N. B. Javitt. 1994. Bile acid synthesis in HepG2 cells: effect of cyclosporin. J. Lipid Res. 35: 1795-1800.
36. Goldstein, J. L., S. K. Baus, and M. S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
37. Pedersen, J. I., I. Björkhem, and J. Gustafsson. 1979. 26-Hydroxylation of C27-steroids by soluble liver mitochondrial cytochrome P-450. J. Biol. Chem. 254: 6464-6469.
38. Fabricant, M., and S. A. Broitman. 1990. Evidence for deficiency of low density lipoprotein receptor on human colonic carcinoma cell lines. Cancer Res. 50: 632-636.
39. Nagata, Y., Y. Hidaka, F. Ishida, and T. Kamei. 1990. Effect of simvaststin (MK-733) on the regulation of cholesterol synthesis in HepG2 cells. Biochem. Pharmacol. 40: 843-850.
40. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85.
41. DeCaprio, J., J. Yun, and N. B. Javitt. 1992. Bile acid and sterol solubilization in 2-hydroxypropyl-beta-cyclodextrin. J. Lipid Res. 33: 441-443.
42. Petrack, B., and B. J. Latario. 1993. Synthesis of 27-hydroxyrholesterol in rat liver mitochondria: HPLC assay and marked activation by exogenous cholesterol. J. Lipid Res. 34: 643-649.
43. Kamps, J. A. A. M., and T. J. C. Van Berkel. 1992. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line HepG2 by β-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Eur. J. Biochem. 206: 973-978.
44. Kilsdonk, E. P. C., P. G. Yancey, G. W. Stoudt, F. W. Bangerter, W. J. Johnson, M. C. Phillips, and G. H. Rothblat. 1995. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270: 17250-17256.
45. Gennis, R. B., and A. Jonas. 1977. Protein-lipid interactions. Annu. Rev. Biophys. Bioeng. 6: 195-238.
46. Farese, R. V., M. Standaert, B. Yu, H. Hernandez, and D. R. Cooper. 1993. 2-Hydroxypropyl-β-cyclodextrin enhances phorbol ester effects on glucose transport and/or protein kinase C-translocation to the plasma membrane in rat adipocytes and soleus muscles. J. Biol. Chem. 268: 19949-19955.
47. Garay, R. P., J. C. Feray, C. Nazaret, K. Fanous, M. J. Villegas, and J. F. Letavernier. 1994. A new approach for the in vitro evaluation of cyclodextrin effects on cellular membranes of human cells. Conception de Medicaments. Abstract P4.1.48.
48. Lange, Y., J. Ye, and F. Strebel. 1995. Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells. J. Lipid Res. 36: 1092-1097.
49. Smith, L. L., J. I. Teng, Y. Y. Lin, P. K. Seitz, and M. F. McGehee. 1981. Sterol metabolism XLVII. Oxidized cholesteryl esters in human tissues. J. Steroid Biochem. 14: 889-900.
50. Szedkacsek, S. E., E. Wasowicz, S. A. Hulea, H. I. Nishida, F. A. Kummerow, and T. Nishida. 1995. Esterification of oxysterols by human plasma lecithin:cholesterol acyltransferase. J. Biol. Chem. 270: 11812-11819.
51. Gurecki, J., V. Warty, and A. Sanghvi. 1985. The transport of cyclosporine in association with plasma lipoprotems in heart and liver transplant patients. Transplantation Proceedings. 17: 1997-2002.
52. Ballantyne, C. M., E. J. Podet, W. P. Patsch, Y. Harati, V. Appel, A. Gotto, Jr., and J. B. Young. 1989. Effects of cyclosporine therapy on plasma lipoprotein levels. J. Am. Med. Assoc. 262: 53-56.
53. Yokoyama, C., X. Wang, M. R. Briggs, A. Admon, J. Wv, X. Hua, J. L. Goldstein, and M. S. Brown. 1993. SREBP-1, a basic helix-loop-helix-leucine zipper protein that controls transcription of the LDL receptor gene. Cell. 75: 187-197.
54. Wang, X., M. R. Briggs, X. Hua, C. Yokoyama, J. L. Goldstein, and M. S. Brown. 1993. Nuclear protein that binds sterol regulatory element of LDL receptor promoter. II. Purification and characterization. J. Biol. Chem. 268: 14497-14504.
55. Wang, X., R. Sato, M. S. Brown, X. Hua, and J. L. Goldstein. 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 77: 53-62.
56. Axelson, M., and O. Larsson. 1995. Low density lipoprotein (LDL) cholesterol is converted to 27-hydroxycholesterol in human fibroblasts. J. Biol. Chem. 270: 15102-15110.
57. Ballantyne, C. M., G. L. Vega, C. East, G. Richards, and S. M. Grundy. 1987. Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis. Metabolism. 36: 270-276.
58. Nakashima, N., Y. Sakai, H. Sakai, T. Yanase, M. Haji, F. Umeda, S. Koga, T. Hoshita, and H. Nawata. 1994. A point mutation in the bile acid biosynthetic enzyme sterol 27-hydroxylase in a family with cerebrotendinous xanthomatosis. J. Lipid Res. 35: 663-668.
59. Javitt, N. B., E. Kok, S. Burstein, B. Cohen, and J. Kutscher. 1981. 26-Hydroxycholesterol. Identification and quantitation in human serum. J. Biol. Chem. 256: 12644-12646.
60. Fumagalli, R., G. Galli, and G. Urna. 1971. Cholestanol and 26-hydroxcholesterol in normal and atherosclerotic human aorta. Life Sci. 10: 25-33.